Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "IFF"

1803 News Found

More men under 50 seeking help for low testosterone: Apollo Spectra Hospital
Hospitals | June 18, 2026

More men under 50 seeking help for low testosterone: Apollo Spectra Hospital

Hospital data reveals a sharp rise in consultations related to hormonal health, erectile dysfunction and male fertility, highlighting growing awareness among younger men.


Vygon secures Health Canada approval for next-generation Stiletto Extended-Dwell Catheter
Medical Device | June 17, 2026

Vygon secures Health Canada approval for next-generation Stiletto Extended-Dwell Catheter

Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care


We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI
R&D | June 16, 2026

OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI

The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months


ZoBio launches DEL platform to accelerate drug discovery for challenging targets
Biopharma | June 15, 2026

ZoBio launches DEL platform to accelerate drug discovery for challenging targets

New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography


Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
News | June 15, 2026

Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers

Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise


Ryvu advances romaciclib program as FDA clears AML trial expansion
Clinical Trials | June 13, 2026

Ryvu advances romaciclib program as FDA clears AML trial expansion

The regulatory decision follows promising results from RIVER-81


Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
People | June 13, 2026

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor

Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders


Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
News | June 12, 2026

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases

The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients